title: Dome shaped macula associated with myopic retinochoroidosis. Use of spironolactone.
abstract: METHODS
  The cases are presented of three women of 22, 36 and 55 years old with bilateral myopic retinochoroidosis. They had unilateral decreased visual acuity, normal bilateral tonometry, and biomicroscopy. Funduscopy showed bilateral and unilateral myopic maculopathy, and Optical Coherence Tomography (OCT) showed a dome shaped macula with neurosensory detachment. Treatment was started with spironolactone and an improvement by OCT was shown in all cases.
  
  
  CONCLUSIONS
  The etiopathogenic mechanism of the dome shaped macula is discussed. OCT demonstrated to be the fundamental test in the follow-up of this condition. After the evidence shown, initial treatment with spironolactone is suggested.
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España. Electronic address: procha975@yahoo.es.
authors.forename: P
authors.initials: P
authors.lastname: Rocha Cabrera
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España.
authors.forename: L
authors.initials: L
authors.lastname: Cordovés Dorta
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España.
authors.forename: D
authors.initials: D
authors.lastname: Ángel Pereira
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España.
authors.forename: J A
authors.initials: JA
authors.lastname: Abreu Reyes
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España.
authors.forename: M J
authors.initials: MJ
authors.lastname: Losada Castillo
authors.affiliation: Instituto de Enfermedades Tropicales y Salud Pública, Universidad de La Laguna, La Laguna, Tenerife, España.
authors.forename: J
authors.initials: J
authors.lastname: Lorenzo Morales
authors.affiliation: Servicio de Oftalmología, Hospital Universitario de Canarias, La Laguna, Tenerife, España.
authors.forename: M Á
authors.initials: MÁ
authors.lastname: Serrano García
mesh_terms: D000328:Adult; D002825:Chorioretinitis / Q000188:drug therapy / Q000209:etiology*; D057915:Drug Substitution; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000473:pathology*; D008875:Middle Aged; D009216:Myopia / Q000209:etiology* / Q000503:physiopathology; D000069579:Ranibizumab / Q000627:therapeutic use; D018161:Receptors, Mineralocorticoid / Q000378:metabolism; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use*; D041623:Tomography, Optical Coherence; D055815:Young Adult
chemical_list: D018161:Receptors, Mineralocorticoid; D011993:Recombinant Fusion Proteins; C533178:aflibercept; D013148:Spironolactone; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab
keywords: Cúpula; Dome; Espironolactona; Etiopathogenic mechanism; Macula; Mecanismo etiopatogénico; Mácula; Spironolactone; Tratamiento; Treatment